臺灣博碩士論文加值系統

Rheumatoid Arthritis簡稱(RA)是一種因自體免疫系統不健全所引發的疾病，早期被誤認為是屬於膠原系統疾病，醫界到目前為止還未能解開其致病的真正原因，類風濕性關節炎主要侵犯的是全身大大小小的關節，而且是對稱性的影響，以手腕、足、膝等關節最常發病，當然偶爾也會侵犯關節的周圍組織或者是身體其他器官，嚴格講起來它是一種全身性的慢性發炎疾病。拜免疫學與分子生物學技術進步神速之賜，近年來用來檢驗引發RA的Rheumatoid factor (RF)的儀器、試劑、分析方法，都不斷推陳出新，本篇使用BNP及Hitachi717兩種不同儀器的定量偵測RF分析方法，再將兩種實驗方法得到的RF值以數值高低取範圍分組與不分組情況作Pearson相關性分析，結果分組不分組皆得到相關係數高達0.998，驗證此次實驗數據無論分不分組並不會影響分析結果，以定量方式驗證兩種設備實驗的數據並無差異的存在，並將BNP及Hitachi717實驗數據之間關係使用直線關係式表示。

Rheumatoid Arthritis (RA) is believed to be an autoimmune disorder. Previous studies have indicated the RA disorder is resulted from the abnormality of collagen system. However, the exact pathogenesis of the disorder has yet to be fully understood. Basically, RA is a systemic and chronic inflammatory event, and even though RA appears to be found in whole body, the joints are the likely target of the disorder. Recent progresses in clinical laboratory have improved the diagnostic capabilities of the disorder and a related component, called Rheumatoid factor (RF), has been identified to be significantly associated with the disorder. However, whether or not the different methodologies used in RA detection will generate various results leading to different diagnosis has not been studied. In this study, two current popular RA detection methods were evaluated. Using the Pearson analysis, a 0.998 of positive correlation between these two different RA measurements have been demonstrated. Furthermore, data acquired from the two different RA detections have also shown a linear correlation. Together all these finding, it was suggested that the current RA detection techniques show strong correlation and reliabilities no matter which method is taken as the diagnosis tool.

壹、 中文摘要••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••• 5
貳、 英文摘要••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••• 6
參、 縮寫檢索表••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••7
肆、 緒論••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••9
伍、 研究動機•••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••20
陸、 實驗材料與方法•••••••••••••••••••••••••••••••••••••••••••••••••••21
柒、 實驗結果•••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••26
捌、 討論•••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••30
玖、 參考文獻•••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••33
拾、 圖表與圖表說明•••••••••••••••••••••••••••••••••••••••••••••••••••36
附錄•••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••42

1.Tan EM. Autoantibodies and autoimmunity: a three-decade perspective. A tribute to Henry G. Kunkel. Ann NY Acad Sci. 1997; 5;815:1-14.
2.Conrad K, Tan EM, Humbel RL, and Shoenfeld Y. Autoantibodies-diagnostic, pathogenic and prognostic relevance. Clin Exp Rheumatol. 1997;15:457-65.
3.Tzang B-S, Chen T-Y, Hsu T-C, Liu Y-C, Tsay GJ. Presentation of autoantibody to proliferating cell nuclear antigen in patients with chronic hepatitis B and C virus infections. Ann Rheumatic dis. 1999;58;10:630-34.
4.Tan EM. Antinuclear antibodies:diagnosis markers for autoimmune diseases and probes for cell biology. Adv Immunol 1989;44:93-151.
5.Ward MM. Evaluative laboratory testing. Arthritis Rheum. 1995;38:1555-63.
6.Shmerline RH, Delbanco T, and Massachusetts B. The rheumatoid factor: a analysis of clinical utility. Am J of Med . 1991; 91:528-534.
7.Tsay GJ, Su C, Chen T, and Lin C. Clinical significance of antibodies to Sm(Smith) and RNP(ribonucleoprotein) in patients with rheumatic diseases. J Formosan Med Ass. 1984;83: 436-43.
8.Mierau R, Genth E. Autoantibodies in rheumatoid arthritis.In:Thomas L, (ed.) Clinical Laboratory Diagnostics, TH Books Verlagsgesellschaft, Frankfurt/Main 1998; 810-3.
9.Dorner RW, Alexander RL, Moore TL. Rheumatoid factors. Clin Chim Acta 1987; 167:1-21.
10.Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31:315-24.
11.Scott DL. Prognostic factors in early rheumatoid arthritis. Rheumatol 2000; 39 (suppl. 1):24-9.
12.U.S. Department of Health and Human Services CDC, Biosafety in Microbiological and Biomedical Laboratories, HHS Publication (CDC) 93-8395; 1999; Section II; 8-16.
13.Ulvestad E, Kanestrom A, Madland TM, et al. Clinical utility of diagnostic tests for rheumatoid factor. Scand J Rheumatol 2001; 30: 87-91.
14.National Committee for Clinical Laboratory Standards. Evaluation of Precision
15.Performance of Clinical Chemistry Devices; Approved Guideline.NCCLS, USA, 1999.
16.Winchester RJ. Characterization of IgG complex in patients with rheumatoid arthritis. Ann NY Acad Sci. 1975;256:73-81.
17.Moore TL, Dorner RW. Rheumatoid factors. Clin Biochem 1993;26:75-84.Shmerling RH, Delbanco TL. The Rheumatoid factors; an analysis of clinical utility. Am J Ned. 1991;91:528-34.
18.Mannlk M. Rheumatoid factors in the pathogensis of rheumatoid arthritis. J Rheumatol Suppl 1992;32:46-9.
19.Mierau R,Genth E.. Autoantibodies in rheumatoid arthritis.in; Thomas L clinical Laboratory Diagnostics 1st ed. Frankurt; TH-Books verlagsgesellschaft;1998.p.810-3.
20.Singer JM, Plotz CM.The latex fixation test: application to the serologic diagnosis of rheumatoid arthritis. Am J Med. ;1956;21:888-92.
21.Young DS.Effects of drugs on clinical laboratory tests, 3th ed. AACC press ,1997.
22.Shmerling RH,Delblanco TH.The Rheumatoid factors. an analysis of clinical utility. Am J Med. 1991:91:528-34.
23.Sager D,Wermick RM, Davey MP. Assays for rheumatoid factor: a review of their utility and limition in clinical practice. Lab Med. 1992;23:15-8.
24.Tietz Textbook of Clinical Chemistry, 3rd edition. Burtis CA, Ashwood ER. WB Saunders Co.,1999.
25.Friedman and Young. Effects of disease on clinical laboratory tests, 3th ed. AACC press,1997.
26.David E. Trentham, Alexander S. Townes, Andrew H. Kang and John R. David. Humoral and Cellular Sensitivity to Collagen in Type II Collagen-Induced Arthritis in Rats. J Clin Invest. 1978;61(1):89–96.
27.David E. Trentham, Roselynn A. Dynesius, and John R. David. Passive Transfer by Cells of Type II Collagen-Induced Arthritis in Rats. J Clin Invest. 1978 August; 62(2): 359–366.